Dual antiplatelet therapy (clopidogrel and aspirin) is associated with increased all-cause mortality after carotid revascularization for asymptomatic carotid disease
Conclusions: In this retrospective, single-institution study, the use of dual antiplatelet therapy (aspirin plus clopidogrel) in patients intervened for asymptomatic carotid disease was related to increased all-cause mortality, whereas it did not significantly influence the outcome in patients with symptomatic carotid disease.
Source: Journal of Vascular Surgery - Category: Surgery Authors: Francisco Alcocer, Zdenek Novak, Bart R. Combs, Bruce Lowman, Marc A. Passman, Marjan Mujib, William D. Jordan Tags: Clinical research studies Source Type: research
More News: Aspirin | Bleeding | Clopidogrel | Middle East Health | Plavix | Stroke | Study | Surgery